Nachrichten zur Teva Pharmaceutical Industries Limited Aktie

Teva seeks to reinvent itself as branded drug developer

After years of shrinking revenue, new CEO Richard Francis is switching the emphasis to innovation. "Globes" looks at Tevas drug…

Gilead, Teva acquitted in pay for delay generic HIV drugs case

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Deckers (DECK) to Benefit From Brand Strength Amid Headwinds

Deckers Outdoor (DECK) is well poised to benefit from strength across its HOKA and Teva brands, store expansion initiatives and…

Form 8-K TEVA PHARMACEUTICAL INDU For: Jun 15

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva settles price-fixing claims with State of Kentucky for $1.41M (update)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceuticals Reaches Deal With Kentucky AG To Settle Price-fixing Claims

PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, the U.S. subsidiary of Teva Pharmaceutical Industries Ltd. (TEVA), Monday said it has reached…

Teva settles price-fixing claims with State of Kentucky for $1.41B

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO),…

Why did Teva fall 20% in April-May?

An SEC filing reveals that major US-based shareholder Capital Research Global Investors sold its entire holding....…

Teva Pharmaceutical settles $193M opioid suit with the state of ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pharmaceutical Giants Set $19 Billion Opioid Settlement as States Debate How to Spend It

Teva, Allergan, CVS and Walgreens said enough states agreed to final agreements, adding to the billions flowing to communities....…

Teva, Walgreens, CVS, AbbVie to pay $17.3B in national opioid settlement

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

NY AG approves $17.3 billion opioid settlement with CVS, Walgreens, Teva and AbbVie’s Allergan

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

BRIEF-Attorney General James Announces Final National Settlement Agreements For $17.3 Bln With Teva, CVS And Walgreens - Statement

...June 9 (Reuters) - * ATTORNEY GENERAL JAMES ANNOUNCES FINAL NATIONAL......…

Hot Stocks: CVNA rises on upbeat Q2 outlook; GME dips on firing CEO; AMZN, TEVA gain; SIG, GME fall

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Settles Nationwide Opioids Agreement

PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd (TEVA), announced on Thursday that it…

Teva completes US nationwide settlement on opioids

Teva will pay Nevada $193 million over 20 years, making it the final state to conclude an agreement with the…

Teva Pharmaceutical settles opioid litigation with all 50 states

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K TEVA PHARMACEUTICAL INDU For: Jun 08

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva to pay Nevada $193 million over role in opioid epidemic

...By Brendan Pierson (Reuters) - Teva Pharmaceutical Industries......…

Phil, Teva Partner To Help Patients To Receive, Refill Digihaler Medication

PETAH TIKVA (dpa-AFX) - Phil Inc. announced an agreement with Teva Pharmaceuticals that will make Digihaler products available for prescription…

Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy?

Its unclear whether the pivot will be enough to halt its recent decline....…

Teva Pharmaceutical S&P rating outlook changed to stable from positive

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Deckers (DECK) Q4 Earnings Beat Estimates, HOKA Brand Aids

Deckers Outdoors (DECK) fourth-quarter fiscal 2023 results reflect a 7.5% increase in net sales, driven by the strength of its…

Teva is Said to Explore Options for Bowel Inflammation Drug

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

TEVA Pharmaceutical: Ersteinschätzung

New York (www.aktiencheck.de) - Rating-Update: Thibault Boutherin, Analyst von Morgan Stanley, startet die Coverage der Aktie von TEVA Pharmaceutical Industries Ltd.…

Der Branchenriese Teva verliert Interesse an Generika – Medikamente dürften noch knapper werden

Medikamentenkopien können nicht billig genug sein. Der neue Chef des weltweit zweitgrössten Generikaherstellers, Teva Pharmaceuticals, zieht aus dem Preiskampf seine…

3 Generic Drug Stocks to Watch Amid Macro Headwinds

The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite…

Sun: Teva drags TASE down

Teva led the declines today as Tower and Nova bucked the market....…

Teva long-acting schizophrenia drug Uzedy reduces relapse risk up to 80%

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Watch Teva to Make Fewer Generic Drugs

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Plans to Cut Back Generic Drug Production Even As Shortages ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Will Slim Down Its Generic Drug Business

The new corporate strategy aims to deliver a “pivot to growth," the drugmaker said....…

Why Teva Pharmaceutical Stock Is Jumping Today

Investors are reacting positively to Tevas new growth strategy....…

Teva targets growth through innovation

Tevas new strategy stresses growth through branded drugs and biosimilars. The company sees Austedo sales of $2.7 billion in 2027....…

Teva gains after announcing new growth strategy; Evercore upgrades

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceutical announces new growth strategy built on biosimilars, innovation

Teva Pharmaceutical Industries on Thursday launched a new “pivot to growth” strategy, based on existing growth drivers like Austedo and…

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

...By Blake Brittain WASHINGTON (Reuters) -The U.S. Supreme Court......…

UPDATE 1-US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

... 15 (Reuters) - The U.S. Supreme Court on Monday declined to hear Teva......…

Teva-Aktie in Rot: Chef der Teva-Tochter Ratiopharm warnt vor weiteren Arzneimittel-Engpässen

Der Geschäftsführer des Ulmer Arzneimittelherstellers Ratiopharm, Andreas Burkhardt, sieht viele weitere Engpässe in der Medikamentenversorgung auf Deutschland zukommen....…

Hot Stocks: UPST, LI gain on strong earnings; CELH rise on an analyst upgrade; TWLO, TEVA, OXY slide

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceutical Industries (TEVA) Q1 2023 Earnings Call Transcript

TEVA earnings call for the period ending March 31, 2023....…

Compared to Estimates, Teva Pharmaceutical Industries Ltd. (TEVA) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Teva Pharmaceutical Industries Ltd. (TEVA) give a sense of how the business performed…

Teva Pharmaceutical Shares Slide 12% on 1Q Earnings Miss

Teva Pharmaceutical Shares Slide 12% on 1Q Earnings Miss...…

Teva Pharm Q1 net profit slides, maintains 2023 forecast

...JERUSALEM (Reuters) -Israel-based Teva Pharmaceutical Industries......…

UPDATE 1-Teva Pharm Q1 net profit slides, maintains 2023 forecast

... (Reuters) - Israel-based Teva Pharmaceutical Industries reported a drop......…

Teva misses on profit, beats analysts on revenue

The Israeli company reported non-GAAP earning per share of just $0.40, while market expectations were $0.56....…

ROUNDUP: Teva Pharma Reaffirms FY23 Outlook

PETAH TIKVA (dpa-AFX) - While reporting financial results for the first quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) reaffirmed…

Teva Pharm Q1 net profit slides, revenue flat

...JERUSALEM, May 10 (Reuters) - Israel-based Teva Pharmaceutical......…

Teva Pharmaceutical Industries Limited Q1 Earnings Summary

PETAH TIKVA (dpa-AFX) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):Earnings: -$205 million in Q1 vs.…